Miyanishi H, Uno Y, Iwata M, Kikuchi Y, Yamamori H, Yasuda Y, Ohi K, Hashimoto R, Yoshida S, Goto Y, Sumiyoshi T, Nitta A.  Investigating DNA methylation of SHATI/NAT8L promoter sites in blood of unmedicated patients with depression.  Biol Pharm Bull.  43 (7) 1067-1072 (2020)

Wulaer B, Kunisawa K, Hada K, Jaya Suento W, Kubota H, Iida T, Kosuge A, Nagai T, Yamada K, Nitta A, Yamamoto Y, Saito K, Mouri A, Nabeshima T.　 Shati/Nat8l Deficiency Disrupts Adult Neurogenesis and Causes Attentional Impairment Through Dopaminergic Neuronal Dysfunction in the Dentate Gyrus. J Neurochem, 2020,

Ｙuka K, Nishizawa D, Hasegawa J, Uno K, Miyanishi H, Ujike H, Ozaki N, Inada T, Iwata N, Sora I,  Iyo M, Yamada M, Kondo N, Won MJ, Naruse N, Uehara-Aoyama K, Ikeda K, and Nitta A.  A single medical marker for diagnosis of methamphetamine addiction – DNA methylation of SHATI/NAT8L promoter sites from patient blood.  Curr Pharm Des, 2020, 26, 1-5;  doi: 10.2174/1381612826666200110111703